Skip to content

Strybol Iben Pharma: what changed

BE 0766.610.695NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€147,626
2024 · €28,777+€118,850
Equity
€158,240
2024 · €154,544+€3,695
Cash
€22,277
2024 · €86,913-€64,636
Balance sheet total
€2.2m
2024 · €184,987+€2.0m

Largest movements

2024 to 2025
Assets
  • Financial fixed assets +€2.0m

    up €2.0m (+2,311%), from €85,170 to €2.1m

  • Receivables within one year +€70,873

    up €70,873 (+649%), from €10,914 to €81,787

    of which Other amounts receivable: +€56,574

  • Cash -€64,636

    down €64,636 (-74.4%), from €86,913 to €22,277

    mainly Investment in fixed assets (net) (-€2.0m) and Contributions, distributions and other (-€143,931)

Equity and liabilities
  • Debts after one year +€1.7m

    first reported in 2025, at €1.7m

  • Current portion of long-term debt +€183,095

    first reported in 2025, at €183,095

  • Other debts +€120,525

    up €120,525, from €0 to €120,525

  • Accrued charges and deferred income +€23,257

    first reported in 2025, at €23,257

Income statement
  • Gross operating margin +€180,152

    up €180,152 (+421%), from €42,753 to €222,904

  • Taxes +€39,369

    up €39,369 (+337%), from €11,699 to €51,068

  • Financial charges +€22,042

    up €22,042 (+2,009%), from €1,097 to €23,139

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €28,777
Gross operating margin +€180,152
Depreciation -€161
Other operating charges +€120
Other operating items +€19
Financial income +€131
Financial charges -€22,042
Taxes -€39,369
Result 2025 €147,626
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€203,260
Investment -€2.0m
Financing +€1.7m
Cash 2024 €86,913
Net result for the year +€147,626
Depreciation +€418
Receivables within one year -€70,873
Deferred charges and accrued income -€17,428
Smaller working-capital items -€265
Other debts +€120,525
Accrued charges and deferred income +€23,257
Investment in fixed assets (net) -€2.0m
Debts after one year +€1.7m
Current portion of long-term debt +€183,095
Contributions, distributions and other -€143,931
Cash 2025 €22,277
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €184,987 €2,177,317 +€2.0m +1,077%
Fixed assets 21/28 €86,314 €2,054,977 +€2.0m +2,281%
Tangible fixed assets 22/27 €1,144 €1,357 +€214 +18.7%
Furniture and vehicles 24 €1,144 €1,357 +€214 +18.7%
Financial fixed assets 28 €85,170 €2,053,620 +€2.0m +2,311%
Current assets 29/58 €98,674 €122,340 +€23,666 +24.0%
Amounts receivable within one year 40/41 €10,914 €81,787 +€70,873 +649%
Trade receivables 40 €10,905 €25,204 +€14,300 +131%
Other amounts receivable 41 €9 €56,583 +€56,574 +623,746%
Cash at bank and in hand 54/58 €86,913 €22,277 -€64,636 -74.4%
Deferred charges and accrued income 490/1 €847 €18,276 +€17,428 +2,057%
Total equity and liabilities 10/49 €184,987 €2,177,317 +€2.0m +1,077%
Equity 10/15 €154,544 €158,240 +€3,695 +2.4%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €149,544 €153,240 +€3,695 +2.5%
Distributable reserves 133 €149,544 €153,240 +€3,695 +2.5%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €30,443 €2,019,077 +€2.0m +6,532%
Amounts payable after more than one year 17 - €1,662,022 +€1.7m
Financial debts 170/4 - €1,662,022 +€1.7m
Amounts payable within one year 42/48 €30,443 €333,798 +€303,355 +996%
Current portion of amounts payable after more than one year 42 - €183,095 +€183,095
Trade debts 44 €141 €3,289 +€3,149 +2,241%
Suppliers 440/4 €141 €3,289 +€3,149 +2,241%
Taxes, remuneration and social security 45 €30,302 €26,889 -€3,414 -11.3%
Taxes 450/3 €30,302 €26,889 -€3,414 -11.3%
Other amounts payable 47/48 €0 €120,525 +€120,525
Accrued charges and deferred income 492/3 - €23,257 +€23,257
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €257 €418 +€161 +62.6%
Other operating charges 640/8 €804 €684 -€120 -14.9%
Non-recurring operating charges 66A €120 €101 -€19 -15.9%
Gross operating margin 9900 €42,753 €222,904 +€180,152 +421%
Operating profit (loss) 9901 €41,572 €221,702 +€180,130 +433%
Financial income 75/76B - €131 +€131
Recurring financial income 75 - €131 +€131
Financial charges 65/66B €1,097 €23,139 +€22,042 +2,009%
Recurring financial charges 65 €1,097 €23,139 +€22,042 +2,009%
Profit (loss) for the period before taxes 9903 €40,475 €198,694 +€158,219 +391%
Income taxes 67/77 €11,699 €51,068 +€39,369 +337%
Profit (loss) for the period 9904 €28,777 €147,626 +€118,850 +413%
Profit (loss) for the period to be appropriated 9905 €28,777 €147,626 +€118,850 +413%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€337,570 to €440,950

Midpoint €380,645 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €158,240
Capitalised earnings €516,900 to €723,660
Indication €337,570 to €440,950

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€158,240
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€158,240

Capitalised earnings

net result for the year (9904)
2025
€147,626
excluding non-recurring income and charges
€147,727
2024
€28,777
excluding non-recurring income and charges
€28,897
2023
€40,473
excluding non-recurring income and charges
€40,475
2022
€80,295
Average result, excluding non-recurring income and charges
€72,366
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€516,900 / €603,050 / €723,660

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.